MEDISIX THERAPEUTICS, INC.

Profile

Company Names

MEDISIX THERAPEUTICS, INC.

Addresses

500 BOYLSTON STREET, SUITE 1380, BOSTON, MA 02116

11 BIOPOLIS WAY, #05-08/09 HELIOS, SINGAPORE, U0 138667

Phone Numbers

617-933-3770
6565355336

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$42,858,686.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-04-01 
$22,500,000.00 
$22,500,000.00 
$0.00 
Debt 
1
2019-09-17 
$20,358,686.00 
$20,358,686.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANDREW 
R. 
BRUCE 
EXECUTIVE OFFICER, DIRECTOR
MEDISIX THERAPEUTICS, INC.
MICHAEL 
 
CARUSI 
DIRECTOR
ENDOGASTRIC SOLUTIONS INC   |  GI DYNAMICS, INC.   |  POWERVISION, INC.   |  GLUMETRICS INC   |  ALTURA MEDICAL, INC.   |  SECOND GENOME, INC.   |  EXPLORAMED NC7, INC.   |  TALLAC THERAPEUTICS, INC.   |  MEDISIX THERAPEUTICS, INC.   |  CALA HEALTH, INC.   |  WILLOW INNOVATIONS, INC.
MICHAEL 
A. 
CARUSI 
DIRECTOR
HOLAIRA, INC.   |  LIGHTSTONE VENTURES, L.P.   |  LIGHTSTONE VENTURES (A), L.P.   |  LIGHTSTONE VENTURES (AIV), L.P.   |  LIGHTSTONE VENTURES (A) (AIV), L.P.   |  LIGHTSTONE SINGAPORE, L.P.   |  CALA HEALTH, INC.   |  NUVAIRA, INC.   |  FOUNDRY THERAPEUTICS 1, INC.   |  MEDISIX THERAPEUTICS, INC.   |  ALLAY THERAPEUTICS, INC.   |  LIGHTSTONE VENTURES III, L.P.   |  APREO HEALTH, INC.
WILLIAM 
 
HARRINGTON 
DIRECTOR
BENVENUE MEDICAL INC   |  VOYAGE MEDICAL INC   |  BAXANO, INC.   |  OSAGE UNIVERSITY PARTNERS II, L.P.   |  RIBON THERAPEUTICS, INC.   |  ATTEROCOR, INC.   |  HYALEX ORTHOPAEDICS, INC.   |  NEUROS MEDICAL, INC.   |  MEDISIX THERAPEUTICS, INC.   |  OSAGE UNIVERSITY PARTNERS IV, LP   |  OUP IV AFF PARTNERSHIP, LP
SARAH 
 
LIM 
EXECUTIVE OFFICER
MEDISIX THERAPEUTICS, INC.
KENNETH 
D. 
NOONAN 
EXECUTIVE OFFICER, DIRECTOR
MEDISIX THERAPEUTICS, INC.
GEORGE 
A. 
POSTE 
DIRECTOR
MEDISIX THERAPEUTICS, INC.
GEORGE 
H. 
POSTE 
DIRECTOR
MONSANTO CO /NEW/   |  MEDISIX THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-08-04
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-04-01 
2021-04-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-04-01 
2019-10-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#